Assessment of second-line antiretroviral regimens for HIV therapy in Africa

BACKGROUND: The efficacy and toxic effects of nucleoside reverse-transcriptase inhibitors (NRTIs) are uncertain when these agents are used with a protease inhibitor in second-line therapy for human immunodeficiency virus (HIV) infection in resource-limited settings. Removing the NRTIs or replacing t...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Paton, N, Kityo, C, Walker, A, al., E
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	Massachusetts Medical Society 2014

Assessment of second-line antiretroviral regimens for HIV therapy in Africa. gan Paton, N, Kityo, C, Hoppe, A, Reid, A, Kambugu, A, Lugemwa, A, van Oosterhout, J, Kiconco, M, Siika, A, Mwebaze, R, Abwola, M, Abongomera, G, Mweemba, A, Alima, H, Atwongyeire, D, Nyirenda, R, Boles, J, Thompson, J, Tumukunde, D, Chidziva, E, Mambule, I, Arribas, JR, Easterbrook, P, Hakim, J, Walker, A, Mugyenyi, P

Cyhoeddwyd 2014

Journal article

Assessment of second-line antiretroviral regimens for HIV therapy in Africa

Eitemau Tebyg